MEDICINOVA, INC. Operating Lease Liability
MEDICINOVA, INC. (MNOV) had Operating Lease Liability of $117.04 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability $117.04K.
- 2026-03-31: Operating Lease, Liability $165.20K.
- 2025-12-31: Operating Lease, Liability $211.46K.
- 2025-09-30: Operating Lease, Liability $255.15K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $117.04K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $165.20K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $211.46K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $255.15K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $301.88K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $355.06K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $405.23K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $457.13K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $492.53K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $569.07K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $626.59K 10-K · filed 2025-02-19 | |
| 2023-09-30 | $669.23K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $720.96K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $631.58K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $681.12K 10-K · filed 2024-02-15 | |
| 2022-09-30 | $722.91K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $771.02K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $796.81K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $826.64K 10-K/A · filed 2023-03-28 | |
| 2021-09-30 | $888.40K 10-Q · filed 2021-11-12 | |
| 2021-03-31 | $127.14K 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $188.73K 10-K · filed 2022-02-16 | $184.75K 10-K · filed 2021-02-19 |
| 2019-12-31 | $399.35K 10-K · filed 2021-02-19 | |
| 2019-09-30 | $450.55K 10-Q · filed 2019-10-24 | |
| 2019-06-30 | $468.76K 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $348.22K 10-Q · filed 2019-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |